Amiodarone-induced thyrotoxicosis type 2: predictors and treatment options
Amiodarone-induced type 2 thyrotoxicosis remains a significant problem of modern endocrinology and cardiology. The unique pharmacological character and multifaceted properties of amiodarone explain its high prescription frequency and the leading position among antiarrhythmic drugs. In its turn, cyt...
Main Authors: | A. S. Ermolaeva, O. A. Biakina, J. P. Sytch, P. Yu. Kopylov, V. V. Fadeev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
MONIKI
2019-05-01
|
Series: | Alʹmanah Kliničeskoj Mediciny |
Subjects: | |
Online Access: | https://www.almclinmed.ru/jour/article/view/1009 |
Similar Items
-
Thyroidectomy in patients with amiodarone-induced thyrotoxicosis
by: U. A. Tsoy, et al.
Published: (2021-08-01) -
Acute myopathy secondary to amiodarone-induced thyrotoxicosis
by: Dave Duggan, et al.
Published: (2021-12-01) -
Amiodarone-induced thyrotoxicosis: state of the art
by: Elena A. Lebedeva, et al.
Published: (2017-10-01) -
DUOX1 Gene Missense Mutation Confers Susceptibility on Type 2 Amiodarone-Induced Thyrotoxicosis
by: Olga Biakina, et al.
Published: (2023-02-01) -
Management of Amiodarone-Induced Thyrotoxicosis at a Cardiac Transplantation Centre
by: Michelle Isaacs, et al.
Published: (2018-08-01)